Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension

NCT02220634 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT02220634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02220634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Lead sponsor
National Jewish Health
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2014
Completion date
May 25, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension